JDJohanda Damanik

Johanda Damanik

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Johanda Damanik has a total of 17 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Prevalence and factors associated with cognitive impairment in rheumatoid arthritis patients: a cross-sectional study

    by Rudy Hidayat, Dian Azzahra, Suryo Anggoro Kusumo Wibowo, Anna Ariane, Faisal Parlindungan, Johanda Damanik, Abirianty Priandani Araminta, Fara Fauzia, Jessica Audrey

    Introduction: Rheumatoid arthritis (RA) is a systemic autoimmune disease which has been associated with an increased risk of cognitive impairment. The objective of this study was to determine the pre­valence and possible predictors of cognitive impairment in a cohort of RA individuals. Material and methods: A cross-sectional study was conducted among RA patients aged ≥ 18 years visiting our rheumatology clinic. Demographic, clinical, and laboratory data were collected. Cognitive function was assessed using the Montreal Cognitive Assessment-Indonesian (MoCA-INA) questionnaire. The subjects were classified as cognitively impaired if they scored less than 26. Bivariate and multivariate logistic regression analyses were performed to identify predictive factors of cognitive impairment. Results: A total of 204 participants were included in the analysis, with a mean age of 48.60 (SD ±12.19) years. The prevalence of cognitive impairment based on MoCA-INA scores was 54.9%, with an overall median MoCA-INA score of 25 (range: 3–30). Subjects in the cognitively impaired group scored significantly lower in nearly all the MoCA domains: visuospatial/executive, naming, attention, delayed recall, abstraction, and language. Based on the multivariate analysis, it was found that older age (OR = 1.045, 95% CI: 1.018–1.073, p = 0.001), low education level (OR = 2.260, 95% CI: 1.153–4.432, p = 0.018), intermediate education level (OR = 3.161, 95% CI: 1.359–7.353, p = 0.008) education level, and glucocorticosteroid (GC) use (OR = 2.147, 95% CI: 1.133–4.070, p = 0.019) were significant predictors of cognitive impairment in this study. Conclusions: Cognitive impairment was identified in 54.9% of RA patients in this study. Older age, lower education levels, and GC use were significantly associated with increased risk of cognitive impairment.

    • 1 July 2025
      • Vol. 57  (3) , 368-373

    Complete Atrioventricular (AV) Block as a Cardiac Complication of Rheumatoid Arthritis: A Rare Case Report.

    by Christian Johan, Fatih Anfasa, Adityo Susilo, Johanda Damanik, Rudy Hidayat, Sumariyono Sumariyono, Rm Suryo Anggoro Kusumo Wibowo, Anna Ariane, Faisal Parlindungan, Abirianty Priandani Araminta

    Atrioventricular block (AVB) is a rare complication of rheumatoid arthritis (RA). Complete AVB in people with RA significantly increases cardiovascular morbidity and doubles the mortality risk. We report on a 48-year-old woman presenting with dyspnea and peripheral edema, with symptoms of polyarthritis for 3 years. Physical findings included bradycardia, bilateral rales, and finger deformities consistent with RA. Electrocardiography featured complete AVB, and a thoracic computed tomography scan showed a mosaic appearance with fibrosis, bronchiectasis, and partial atelectasis of the lungs. Further tests showed elevated levels of C-reactive protein, rheumatoid factor, and several inflammatory cytokines. Transient followed by permanent pacemaker placement was performed along with pharmacological treatments, including intravenous (IV) methylprednisolone pulse therapy and IV tocilizumab. Cardiac involvement in RA usually takes the form of pericardial effusion, heart failure, myocarditis, and coronary artery disease. Complete AVB is a rare but important extra-articular involvement in RA that warrants early recognition and treatment with a pacemaker, anti-inflammatory drugs, and disease-modifying antirheumatic drugs.

  • Open Access

    Frequency and factors associated with loss to follow-up in newly diagnosed rheumatoid arthritis patient: a single-centre study

    by Sumariyono Sumariyono, Rudy Hidayat, Faisal Parlindungan, Suryo Anggoro Kusumo Wibowo, Anna Ariane, Johanda Damanik, Abirianty Priandani Araminta, Ryzkianty Annis Nurdin

    Introduction: Lost to follow-up (LTFU) rheumatoid arthritis (RA) patients constitute a population that potentially experiences worsening of their disease. This study aimed to determine the frequency of LTFU and the possible associated factors in newly diagnosed RA patients in our outpatient clinic.Material and methods: A retrospective cohort study was conducted using 260 newly diagnosed RA patients. Those who did not attend their scheduled appointment for more than 3 months were defined as LTFU. We used a Likert scale questionnaire to explore the perception and the possible reasons for LTFU by phone. Bivariate and multivariate logistic regression analyses were performed to explore the factors associated with LTFU.Results: There were 65 patients (25%) who were LTFU. We contacted 34 of them and selected 34 age-matched routinely followed-up (RFU) patients as controls. The reasons for LTFU were distance from house to hospital constraints (76%), busy (56%), transportation constraints (38%), dissatisfaction with the outpatient clinic service (21%), lack of information about their disease (18%), having other comorbidities that compelled them to go to another department’s clinic (15%), difficulties understanding the clinic registration flow system (9%), and having minimal symptoms (6%). Using the c2 test, we found that transportation constraints and busyness were significantly different between LTFU and routinely followed up patients (p-value 0.008 and 0.200, respectively). After multivariate analysis, transportation constraints remained a significant factor (OR = 6.397; 05% CI: 1.622–25.228).Conclusions: Among newly diagnosed RA patients, 65 (25%) were LTFU. Transportation constraints and busyness were factors associated with LTFU. Further multivariate analysis showed that the factor transportation constraints was significantly associated with LTFU of RA patients in this study.


    • 1 January 2021
      • Vol. 53  (2) , 213-220

    Type 2 Diabetes Mellitus and Cognitive Impairment

    by Johanda Demanik, Em Yunir

    Type 2 diabetes mellitus (T2DM) is strongly associated with lower performance on multiple domains of cognitive function and with structural abnormalities of the brain. With the growing epidemic of diabetes and aging population, neural complications of diabetes are expected to rise and becoming a challenge for future health implications. Understanding pathophysiology, factors associated with this complication, manifestation of cognitive impairment and various metabolic and neuroradiologic markers suggestive of this pathologic condition is crucial for proper management of this potentially debilitating complication of T2DM. This review will discuss briefly important aspects of cognitive impairment in T2DM.